-+ 0.00%
-+ 0.00%
-+ 0.00%

Soligenix Advances Phase 3 FLASH2 Trial for HyBryte in Cutaneous T-Cell Lymphoma

Reuters·02/12/2026 12:34:24

Please log in to view news